BridgeBio Oncology Therapeutics, Inc. Common Stock
XNAS:BBOT
12.31
$19.69 - 200.00
$11.50 - 14.00
$12.09
$12.44
$12.12
$12.18
14.04
8.5
37984
134993.3
43180932.27
Chart
TendieTensor AI Analysis
Company
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
Fundamentals
-13.270000
2.182470
-1.03
100
BBG01L3GYF02
BBG01L3GYF11
79.20M
79.20M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own BBOT. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.